APA

Mocali A., Cedrola S., Della Malva N., Bontempelli M., Mitidieri V. A. M., Bavazzano A., Comolli R., Paoletti F. & La Porta C. A. M. (20050203). Increased plasma levels of soluble CD40, together with the decrease of TGF beta 1, as possible differential markers of Alzheimer disease. : Experimental gerontology.

Chicago

Mocali A, Cedrola S, Della Malva N, Bontempelli M, Mitidieri V A M, Bavazzano A, Comolli R, Paoletti F and La Porta C A M. 20050203. Increased plasma levels of soluble CD40, together with the decrease of TGF beta 1, as possible differential markers of Alzheimer disease. : Experimental gerontology.

Harvard

Mocali A., Cedrola S., Della Malva N., Bontempelli M., Mitidieri V. A. M., Bavazzano A., Comolli R., Paoletti F. and La Porta C. A. M. (20050203). Increased plasma levels of soluble CD40, together with the decrease of TGF beta 1, as possible differential markers of Alzheimer disease. : Experimental gerontology.

MLA

Mocali A, Cedrola S, Della Malva N, Bontempelli M, Mitidieri V A M, Bavazzano A, Comolli R, Paoletti F and La Porta C A M. Increased plasma levels of soluble CD40, together with the decrease of TGF beta 1, as possible differential markers of Alzheimer disease. : Experimental gerontology. 20050203.